Silverman v. Motorola, Inc.
798 F. Supp. 2d 954
N.D. Ill.2011Background
- Plaintiffs allege Motorola and certain officers violated the Securities Exchange Act §10(b) and Rule 10b-5 based on the July 2006–January 2007 class period.
- Plaintiffs claim the Mobile Devices segment relied on Freescale for 3G handset ICs, which delayed release of 3G phones and harmed earnings in 2006.
- Defendants argued these 3G statements were truthful, with no scienter, and IP licensing disclosures were not misleading; they moved for summary judgment.
- The court certified a class of persons who purchased Motorola stock during the class period and denied summary judgment, allowing trial on contested issues.
- Plaintiffs introduced evidence of two IP-licensing transactions (Freescale and Qualcomm) in September 2006 and related disclosures in fall 2006, which defendants contend were properly disclosed and non-revenue-implicative.
- The court identified disputed facts regarding (a) truthfulness of 3G statements, (b) materiality of 3G products to Motorola’s results, (c) scienter and the disclosure of IP transactions, and (d) loss causation.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Were Motorola's 3G statements false or misleading? | Plaintiffs contend July–October 2006 statements conveyed more than on-track 3G launches and misled about readiness for Q4 demand. | Defendants claim statements were true when made and did not misstate 3G readiness. | Genuine disputes exist on material truth of 3G statements. |
| Materiality of the 3G statements to investors and Motorola's finances | 3G is material; statements tied to flagship products and holiday ramp; IP revenue and forecasts made 3Q06 material. | IP revenue was a minor component; internal forecasts showed limited 3G impact and market would absorb it. | Materiality disputed; jury could find 3G material to investors. |
| Whether IP-licensing transactions support scienter or misrepresentation | Defendants knew or were reckless about misreporting/disclosing Freescale and Qualcomm IP deals; motive and opportunity shown. | Robust disclosure process and GAAP compliance negate scienter; reliance on internal controls immunizes intent. | There is a genuine dispute on scienter and disclosure of IP transactions. |
| Whether Motorola's disclosures were misleading regarding IP transactions | Disclosures understated the significance of IP deals to margins and misled about recurring nature of IP income. | Disclosures fairly disclosed IP contribution and differentiated recurring vs. non-recurring items. | Disputed whether disclosures were misleading. |
| Loss causation linking alleged misstatements to stock price declines | Corrective disclosures (Nov 7, 2006; Jan 4, 2007; Mar 21, 2007) revealed hidden fraud, causing declines. | Dura governs; need to show a direct causal link; some disclosures did not relate to fraud. | Genuine disputes exist as to loss causation and corrective-disclosure effects. |
Key Cases Cited
- Matrixx Initiatives, Inc. v. Siracusano, 131 S. Ct. 1309 (U.S. 2011) (materiality shown by substantial likelihood disclosure would alter total mix)
- Janus Capital Grp., Inc. v. First Derivative Traders, 131 S. Ct. 2296 (U.S. 2011) (reliance element and misstatement requirements clarified)
- Erica P. John Fund, Inc. v. Halliburton Co., 131 S. Ct. 2179 (U.S. 2011) (loss causation and proximate cause; market effects of misstatements)
- Dura Pharms., Inc. v. Broudo, 544 U.S. 336 (U.S. 2005) (plaintiffs must prove that misstatement caused economic loss)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (U.S. 2007) (plaintiffs must show loss causation and causal link to the misstatement)
- Stoneridge Investment Partners, LLC v. Scientific-Atlanta, Inc., 552 U.S. (selector) (U.S. 2008) (financially linked deception and the need for causal link)